## IO Biotech Faces Setback as Melanoma Vaccine Trial Nears Meaning
It’s been a bumpy month for IO biotech, which will regroup after its lead candidate narrowly missed statistical significance for progression-free survival (PFS) in a phase 3 trial (NCT05155254) for patients with previously untreated advanced melanoma, with results presented Monday at the 50th Congress of the European Society for Medical Oncology (ESMO) in Berlin, Germany.1 Topline results had been shared with FDA weeks prior, adn Fierce Biotech reported that meeting prompted the company to lay off half its employees.2
IO Biotech is developing the immune-modulatory cancer vaccine Cylembio (imsapepimut and etimupepimut, adjuvanted) to combine with the PD-1 inhibitor pembrolizumab (Keytruda; Merck). The phase 3 data in melanoma came 5 years after promising phase 1/2 results for 30 patients were presented at ESMO,3 showing how the vaccine, then used with nivolumab (Opdivo; Bristol Myers Squibb), met its primary end point with an objective response rate of 80%, and median PFS (mPFS) “was not reached for responding patients.”4
In an interview earlier this year with The American Journal of Managed Care® (AJMC), IO Biotech co-founder Mads Hald Andersen, DMSc, PhD, explained how these off-the-shelf vaccines battle cancer by disrupting the tumor microenvironment (TME): they kill tumors cells and set loose effector T cells to create an anti-tumor, proinflammatory TME.4
Personalized Cancer Vaccine Shows Promise in Combination with Pembrolizumab
Table of Contents
A phase 2 trial evaluating the combination of a personalized cancer vaccine with pembrolizumab demonstrated encouraging results, particularly in patients with PD-L1-negative tumors.the study, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, investigated the impact of the vaccine – designed to stimulate an immune response against individualized neoantigens – when added to pembrolizumab in patients with advanced melanoma.
While the overall progression-free survival (PFS) did not reach statistical significance (HR 0.77; 95% CI, 0.58-1.00, P* = .0558), subgroup analyses revealed notable benefits. Patients with PD-L1-negative tumors experienced a significant enhancement in PFS with the combination, showing a difference of 16.6 months versus 3.0 months with pembrolizumab alone (HR 0.54; 95% CI, 0.35-0.85). Positive trends were also observed in patients with *BRAF V600 mutations (HR 0.60; 95% CI, 0.40-0.90) and elevated lactate dehydrogenase (LDH) levels (HR 0.60; 95% CI, 0.39-0.92).
The safety profile of the combination was favorable, with no increase in immune-mediated adverse events (34.0% vs 38.4%) or grade 3 or higher treatment-related adverse events (TRAEs) (14.5% vs 15.6%) compared to pembrolizumab alone. Injection-site reactions, mostly grade 1, were reported in 56% of patients receiving the vaccine.
Researchers also observed expanded IDO1- and PD-L1-specific T-cell responses in the vaccine arm, supporting the therapy’s proposed immune-modulatory mechanism.
according to lead investigator Dr. Johanna Hassel, the duration of response appeared longer in the vaccine arm without added systemic toxicity. She suggested the vaccine offered the most benefit to patients with PD-L1-negative tumors, potentially due to the immune-unfriendly surroundings characteristic of these tumors, which the vaccine effectively modulated.
Despite the promising findings, Dr. Hassel acknowledged the need for further inquiry,stating that a new trial is likely necessary to definitively confirm the benefits of the combination and meet regulatory requirements.
“`html
the Gut-Brain Connection: Understanding its Impact on Health
Published: 2025/10/22 07:05:36
What is the Gut-Brain Connection?
The gut-brain connection is a bidirectional dialog system between the gastrointestinal tract and the brain. For years, scientists believed the brain controlled everything, but research now reveals the gut plays a significant role in influencing brain health, and vice versa. This complex interplay involves neurological, hormonal, and immunological pathways.
The Role of the Microbiome
Central to this connection is the gut microbiome – the trillions of bacteria,fungi,viruses,and other microorganisms residing in your digestive tract. These microbes aren’t just passive inhabitants; they actively influence your health in numerous ways. A diverse and balanced microbiome is crucial for optimal gut-brain communication.
- Neurotransmitter Production: Gut bacteria produce neurotransmitters like serotonin, dopamine, and GABA, which directly impact mood, anxiety, and cognitive function.
- immune System Modulation: Approximately 70% of the immune system resides in the gut.The microbiome helps train and regulate immune responses, influencing inflammation levels throughout the body, including the brain.
- Vagus Nerve Stimulation: The vagus nerve acts as a direct communication line between the gut and the brain.Gut microbes can stimulate this nerve,sending signals that affect brain activity.
How the Gut impacts Brain Health
the gut-brain connection influences a wide range of neurological and psychological conditions.
Mental Health Disorders
Research increasingly links gut dysbiosis (an imbalance in the gut microbiome) to mental health disorders such as:
- Depression: Altered gut microbiome composition has been observed in individuals with depression.
- Anxiety: Gut bacteria can influence the hypothalamic-pituitary-adrenal (HPA) axis, the body’s stress response system, impacting anxiety levels.
- Autism Spectrum Disorder (ASD): Many individuals with ASD experience gastrointestinal issues and altered gut microbiomes.
A study published in Nature Neuroscience highlights the potential for manipulating the gut microbiome to improve mental health outcomes.
Neurodegenerative Diseases
The gut-brain connection is also implicated in neurodegenerative diseases like:
- Alzheimer’s Disease: Gut dysbiosis and increased intestinal permeability (“leaky gut”) can contribute to neuroinflammation, a hallmark of Alzheimer’s.
- Parkinson’s Disease: Changes in the gut microbiome have been observed in Parkinson’s patients, and gut inflammation may contribute to disease progression.
Cognitive Function
A healthy gut microbiome supports optimal cognitive function, including memory, learning, and focus. Inflammation in the gut can impair cognitive abilities.
Improving your Gut Health to Benefit Your Brain
Fortunately, you can actively improve your gut health and, consequently, your brain health.
Dietary Changes
What you eat directly impacts your gut microbiome.Focus on:
- Fiber-Rich foods: Fruits, vegetables, whole grains, and legumes provide fuel for beneficial gut bacteria.
- Fermented Foods: Yogurt,kefir,sauerkraut,kimchi,and kombucha contain probiotics – live microorganisms that can enhance gut diversity.
- Prebiotic Foods: Onions, garlic, asparagus, and bananas contain prebiotics – non-digestible fibers that feed beneficial gut bacteria.
- Limit Processed Foods, Sugar, and Artificial Sweeteners: These can disrupt the gut microbiome and promote inflammation.
Lifestyle factors
Beyond diet, consider these lifestyle factors:
- Stress Management: Chronic stress negatively impacts the gut microbiome. Practice stress-reducing techniques like meditation, yoga, or deep breathing.
- Regular Exercise: Physical activity promotes gut microbial diversity.
- Adequate Sleep: Sleep deprivation can disrupt the gut microbiome.
- Judicious Antibiotic Use: Antibiotics can kill both harmful and beneficial bacteria. Use them only when necessary and under a doctor’s supervision.
FAQ
Q: How quickly can I expect to see results from improving my gut health?
A: It varies, but some people experience improvements in mood and digestion within a few weeks. Significant changes may take several months as the microbiome shifts.
Q: Are probiotics right for everyone?
A: Not necessarily.While generally safe, probiotics can cause digestive upset in some individuals. It’s best to start with a low dose and consult with a healthcare professional.
Q: Can gut health testing provide valuable insights?
A: gut health testing can offer a snapshot of your microbiome composition, but interpretation can be complex.Discuss results with a qualified healthcare provider.